Influence of Profound Muscle Relaxation on Muscle Trauma and Postoperative Pulmonary Function

Sponsor
Ying Xiao (Other)
Overall Status
Unknown status
CT.gov ID
NCT01804933
Collaborator
(none)
72
1
3
13
5.5

Study Details

Study Description

Brief Summary

Although deep anesthesia can produce skeleton muscle relaxation,unnecessary deep anesthesia often had adverse cardiac effects and was related to 2-year mortality in cancer patients.The use of muscle relaxants allowed the depth of anesthesia to be optimized.However, for many anesthesiologists,in fear of residual postoperative neuromuscular blockade,intraoprative administration of muscle relaxants had to be minimized in spite of poor surgical conditions.

This study, however, is designed to test the hypothesis that profound neuromusclular blockade reduces muscle trauma caused by self-retaining retractor and thus cut down postoperative analgesic requirement.On the other hand,profound muscle relaxation can decrease postoperative diaphragmatic dysfunction and abdominal muscle trauma, which can improve postoperative pulmonary function.

Condition or Disease Intervention/Treatment Phase
  • Drug: profound neuromuscular blockade
Phase 4

Study Design

Study Type:
Interventional
Anticipated Enrollment :
72 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
Primary Purpose:
Treatment
Study Start Date :
Jul 1, 2012
Anticipated Primary Completion Date :
Jul 1, 2013
Anticipated Study Completion Date :
Aug 1, 2013

Arms and Interventions

Arm Intervention/Treatment
No Intervention: conventional neuromuscular blockade

No rocuronium will be administered intraoperatively unless there is surgeons' complain or patients movement

Active Comparator: optimal neuromuscular blockade

Rocuronium dose will be infused to maintain depth of NMB at TOF count 1 intraoperatively

Drug: profound neuromuscular blockade
Rocuronium dose will be infused to maintain a depth of NMB to PTC 1~2 intraoperatively

Experimental: profound neuromuscular blockade

Rocuronium dose will be infused to maintain a depth of NMB to PTC 1~2 intraoperatively

Drug: profound neuromuscular blockade
Rocuronium dose will be infused to maintain a depth of NMB to PTC 1~2 intraoperatively

Outcome Measures

Primary Outcome Measures

  1. degree of muscle trauma [72h postoperatively]

    serum CK

Secondary Outcome Measures

  1. postoperative analgesic requirement [7days postoperatively]

    consumption of morphine

Other Outcome Measures

  1. postoperaive pulmonary function [3days postoperatively]

    FEV1 FVC PEF

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 65 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • ASA 1~2,scheduled to undergo upper abdominal surgery by midline incision
Exclusion Criteria:
  • neuromuscular disorder

  • history of malignant hyperthemia

  • allergy to medications used during general anesthesia

Contacts and Locations

Locations

Site City State Country Postal Code
1 The First Affiliated Hospital of Sun Yat-sen University Guangzhou Guangdong China 510080

Sponsors and Collaborators

  • Ying Xiao

Investigators

  • Study Director: Ying Xiao, MD, PhD, First Affiliated Hospital, Sun Yat-Sen University

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Ying Xiao, Associate Professor, First Affiliated Hospital, Sun Yat-Sen University
ClinicalTrials.gov Identifier:
NCT01804933
Other Study ID Numbers:
  • 伦审[2012]326号
First Posted:
Mar 5, 2013
Last Update Posted:
Mar 5, 2013
Last Verified:
Mar 1, 2013
Keywords provided by Ying Xiao, Associate Professor, First Affiliated Hospital, Sun Yat-Sen University
Additional relevant MeSH terms:

Study Results

No Results Posted as of Mar 5, 2013